Dr. Arvind Chaudhry, MD, PhD
Claim this profileMedical Oncology Associates, PS (dba Summit Cancer Centers)
Area of expertise
Solid Tumors
Arvind Chaudhry, MD, PhD has run 5 trials for Solid Tumors. Some of their research focus areas include:
Lung Cancer
Arvind Chaudhry, MD, PhD has run 3 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Medical Oncology Associates, PS (dba Summit Cancer Centers)
Medical Oncology Associates, PS
Clinical Trials Arvind Chaudhry, MD, PhD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting
1 award
Phase 2
10 criteria
Pirtobrutinib vs Ibrutinib
for Chronic Lymphocytic Leukemia
The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment for their cancer. The purpose of Part 2 of this study evaluates pirtobrutinib monotherapy in treatment-naïve participants with CLL/SLL with 17p deletions. Participation could last up to six years for Part 1. Participation could last up to 2 years for Part 2.
Recruiting
2 awards
Phase 3
More about Arvind Chaudhry, MD, PhD
Clinical Trial Related
3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Arvind Chaudhry, MD, PhD has experience with
- Zimberelimab
- Gemcitabine
- Domvanalimab
- Etrumadenant
- Carboplatin
- Pembrolizumab
Breakdown of trials Arvind Chaudhry, MD, PhD has run
Solid Tumors
Lung Cancer
Non-Small Cell Lung Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arvind Chaudhry, MD, PhD specialize in?
Arvind Chaudhry, MD, PhD focuses on Solid Tumors and Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are CLDN18.2 positive.
Is Arvind Chaudhry, MD, PhD currently recruiting for clinical trials?
Yes, Arvind Chaudhry, MD, PhD is currently recruiting for 5 clinical trials in Spokane Washington. If you're interested in participating, you should apply.
Are there any treatments that Arvind Chaudhry, MD, PhD has studied deeply?
Yes, Arvind Chaudhry, MD, PhD has studied treatments such as Zimberelimab, Gemcitabine, Domvanalimab.
What is the best way to schedule an appointment with Arvind Chaudhry, MD, PhD?
Apply for one of the trials that Arvind Chaudhry, MD, PhD is conducting.
What is the office address of Arvind Chaudhry, MD, PhD?
The office of Arvind Chaudhry, MD, PhD is located at: Medical Oncology Associates, PS (dba Summit Cancer Centers), Spokane, Washington 99208 United States. This is the address for their practice at the Medical Oncology Associates, PS (dba Summit Cancer Centers).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.